Consolidated Statements of Earnings | |
Revenue | 32.04B |
Cost of products sold | 30.45B |
Gross margin | 1.59B |
Operating expenses: | |
Distribution, selling, general and administrative expenses | 920M |
Restructuring and employee severance | 9M |
Acquisition-related costs | |
Impairments and loss on sale of assets | |
Litigation (recoveries)/charges, net | 1M |
Operating earnings | 535M |
Other (income)/expense, net | -3M |
Interest expense, net | 44M |
Loss on extinguishment of debt | |
Gain on sale of investment in CareFusion | |
Earnings before income taxes and discontinued operations | 494M |
Provision for income taxes | 184M |
Earnings from continuing operations | |
Earnings/(loss) from discontinued operations, net of tax | |
Net earnings | 309M |
Basic earnings/(loss) per Common Share: | |
Continuing operations | 0.97 |
Discontinued operations | 0.96 |
Net basic earnings per Common Share | |
Diluted earnings/(loss) per Common Share: | |
Continuing operations | |
Discontinued operations | |
Net diluted earnings per Common Share | |
Weighted average number of Common Shares outstanding: | |
Basic | 320M |
Diluted | 322M |